Ratings by Roth Capital (Zegbeth Jallah)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/11/2021 Kodiak Sciences Inc. KOD Upgrade Buy
(Neutral)
88.41
(102.02)
15.39% Details
2/17/2021 Kodiak Sciences Inc. KOD Downgrade Neutral
(Buy)
145.58
(88.41)
-39.27% Details
11/9/2020 Kodiak Sciences Inc. KOD Maintain Buy
(N/A)
 
 
  Details
4/13/2020 Rapt Therapeutics RAPT New Coverage Buy
(N/A)
16.51
(35.36)
114.17% Details
1/8/2020 Kodiak Sciences Inc. KOD New Coverage Buy
(N/A)
67.70
(145.58)
115.04% Details